Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines...

por Oualikene-Gonin, Wahiba, Sautou, Valérie, Ezan, Eric, Bastos, Henri, Bellissant, Eric, Belgodère, Laëtitia, Maison, Patrick, Ankri, Joël
Publicado 2023

Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for M...

por Belgodère, Laëtitia, Pougheon Bertrand, Dominique, Jaulent, Marie Christine, Rabeharisoa, Vololona, Janssens, Walter, Rollason, Victoria, Barbot, Janine, Vernant, Jean Paul, Oualikene Gonin, Wahiba, Maison, Patrick, Ankri, Joel
Publicado 2023

Access to innovation through the national early access program and clinical trials for patients with malignant melanoma

por Christen, Claire, Belgodère, Laetitia, Guillot, Bernard, Jumeau, Céline, Lorence, Annie, Kerouani‐Lafaye, Ghania, Brunel, Liora, Turcry, Florence, Monard, Adrien, Grudé, Francoise, Guyader, Gaëlle, Boudali, Lotfi, Albin, Nicolas
Publicado 2021

Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience

por Belgodère, Laëtitia, Emmerich, Joseph, Albin, Nicolas, Bacon, Trystan, Daynes, Pascale, Vignot, Stéphane, Vial, Thierry, Renaud, Guillaume, Le Saulnier, Carole, Maillard-Couvreur, Corine, Cachet, Mélanie, Veyries, Marie-Laure, Youdarene, Rym, Oualikene-Gonin, Wahiba, Ratignier-Carbonneil, Christelle, Maison, Patrick
Publicado 2023